SEARCH LISTED COMPANY
ANY AUS OR NZ COMPANY
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
| FROM | TO | |
|---|---|---|
| BOTANIX PHARMACEUTICALS LTD | 07/07/2016 | |
| BONE MEDICAL LIMITED | 20/08/2004 | 07/07/2016 |
| REVENIR LIMITED | 22/01/2004 | 20/08/2004 |
| ALIQUOT ASSET MANAGEMENT LIMITED | 20/08/2001 | 22/01/2004 |
| AERODATA HOLDINGS LIMITED | 20/08/2001 |
Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001
Tel : 1300 288 664 or +61 2 9698 5414name changed to Botanix Pharmaceuticals Ltd | 07/07/2016 |
The company is pleased to announce the completion of the transaction to acquire the entire issued capital of Botanix Pharmaceuticals, Inc. by way of a merger to become Botanix Pharmaceuticals Limited. The agreements between the Company and the shareholders of Botanix have been completed. In addition, the Company has raised $3.5 million under the public offer pursuant to the Prospectus and Supplementary Prospectus. | 04/07/2016 |
we understand that on or about this date the company consolidated its shares 1000 for 3333 | 28/06/2016 |
we understand that on or about this date the company consolidated its shares 1000 for 3333 | 28/06/2016 |
The company is pleased to announce that the Prospectus Offer for the acquisition of Botanix Pharmaceuticals has closed heavily oversubscribed following strong support from investors. | 27/06/2016 |
The company issues a supplementary prospectus intended to be read with the prospectus dated 13 May 2016, issued by Bone Medical Limited. | 24/06/2016 |
The company announces the results of its meeting. | 14/06/2016 |
The securities of Bone Medical Limited ("Company") will be suspended from official quotation immediately, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. | 14/06/2016 |
we understand that on or about this date the company consolidated its shares 1 for 50 | 24/01/2014 |
The suspension of trading in the securities of Bone Medical Limited (the "Company") will be lifted prior to the commencement of trading tomorrow, Thursday 29 August 2013, pursuant to Listing Rule 17.9, following the payment of annual listing fees for the year ending 30 June 2014 by the Company. Security Code: BNE | 28/08/2013 |
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Thursday 22 August 2013 is to be suspended from official quotation before the commencement of trading on Friday 23 August 2013. The company has failed to pay to ASX Limited their annual listing fees in respect of the year ending 30 June 2014 and consequently will be suspended from quotation immediately. | 23/08/2013 |
securities reinstated to quotation | 08/03/2011 |
suspended from quotation following failure to lodge its half yearly financial report | 01/03/2011 |
securities reinstated to quotation | 19/12/2007 |
securities suspended from quotation pending an announcement | 13/12/2007 |
we understand that on or about this date the company consolidated its shares 1 for 4 | 23/08/2004 |
name changed from Revenir Limited | 20/08/2004 |
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 10/04/2015 | Robert Towner | -2,500,000 | $0.013 | $32,440.00 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Robert Towner | Non Exec Chairman | 28/01/2014 |
| Graham Griffiths | Non Exec Chairman | 01/07/2016 |
| Peter Young | Managing Director, CEO | 05/04/2011 |
| Matt Callahan | Executive Director | 01/07/2016 |
| William Bosch | Executive Director | 01/07/2016 |
| Brett Tucker | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|
Date of first appointment, title may have changed.
